novel antibiotic produced by streptomyces noursei Da07210

A novel antibiotic 210-A, named as (6S,8aS,9S,11S,12aR)-6-hydroxy-9,10-dimethyldecahydrobenzo[d]azecine-2,4,12(3H)-trione, was isolated from the fermentation broth of Streptomyces noursei Da07210, its structure was unambiguously established by spectral analyses and chemical comparison with related c...

Full description

Saved in:
Bibliographic Details
Published inAntonie van Leeuwenhoek Vol. 96; no. 1; pp. 109 - 112
Main Authors Wu, Xiaopeng, Huang, Huiqin, Chen, Guangying, Sun, Qianguang, Peng, Jie, Zhu, Jun, Bao, Shixiang
Format Journal Article
LanguageEnglish
Published Dordrecht Dordrecht : Springer Netherlands 01.06.2009
Springer Netherlands
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel antibiotic 210-A, named as (6S,8aS,9S,11S,12aR)-6-hydroxy-9,10-dimethyldecahydrobenzo[d]azecine-2,4,12(3H)-trione, was isolated from the fermentation broth of Streptomyces noursei Da07210, its structure was unambiguously established by spectral analyses and chemical comparison with related cycloheximide. Experiments demonstrated that 210-A bore strong activity against Fusarium oxysporum f. sp. cubense race four (Foc race four), which also showed antitumor activity against SMMC-7721 human hepatocarcinoma cells and S180 murine sarcoma, and the IC₅₀ values were 0.77 and 0.74 μg/ml, respectively.
Bibliography:http://dx.doi.org/10.1007/s10482-009-9333-8
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0003-6072
1572-9699
DOI:10.1007/s10482-009-9333-8